The FDA said it would take “decisive steps” to restrict non-approved drugs that use GLP-1 active pharmaceutical ingredients.
Source link
About The Author
FDA Targets Hims & Hers, Other Marketers of Unapproved GLP-1 Weight-Loss Drugs